Assertio Holdings Inc (USD)
ASRT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.80 | 0.85
52-Wk Range- | -
Last Close0.81
Mkt Cap (m)85.85
Dividend yield-
ISINUS04546C1062
Volume685,864.00
Exchange VenueNAS

Company Profile

Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.

Key Information
Price/Earning-
Price/Book1.02
Price/Sales0.31
P/CF1.54
Rev Growth (3 year avg)-20.45
EPS Growth (3 year avg)-
Operating Margin % -0.33
Net Margin %-94.64
Return on Equity-156.10
Debt/Equity6.18

Documents

Prospectus
en 20/04/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.assertiotx.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)390.36342.74455.90380.72311.77229.50
Operating Income (m)236.81-80.3024.51-28.9364.26-0.75
Net Income (m)131.76-75.74-88.72-102.5036.91-217.20
Basic EPS2.26-1.26-1.45-1.630.58-3.07
Avg. Diluted Shares Outstanding (m)66.3160.1261.3062.7064.2170.72
Balance Sheet
USD201420152016201720182019
Current Assets (m)617.62308.97306.20230.85208.11103.95
Non Current Assets (m)93.381,054.46919.13807.77724.76423.22
Total Assets (m)711.071,363.431,225.341,038.62932.87527.17
Current Liabilities (m)57.50219.63227.24310.58246.04184.55
Total Liabilities (m)------
Total Equity (m)364.45315.06250.79169.51220.3457.96
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-55.92143.8965.5062.1772.5090.48
Capital Expenditure (m)-0.60-26.72-2.86-0.67-5.51-1.48
Figures are quoted in USD unless stated otherwise
0.02 (2.80%)
$
0.84
Last Price